Other

360_2018.png

The 5th annual Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, including the most up-to-date research, data and progress, to help foster collaboration across all IO stakeholders and transform the way cancer is treated.

With the support of its educational partners The Association for Cancer Immunotherapy (CIMT), the Cancer Research Institute (CRI), The Society for Immunotherapy of Cancer (SITC) and other supporters, IO360° attracts global experts and thought leaders from large pharma, biotech, investment community, academia and research organizations as part of the speaking faculty and attendees.

A 20% registration discount applies to CIMT members, using code CIMT.

II. Joint Meeting of DGfl and the Italian Society of Immunology (SIICA)

September 10-13, 2019
München, Germany

For more information, please see www.immunology-conference.de

 

Archive

First International Cancer Immunotherapy Conference

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) joined forces to sponsor the first International Cancer Immunotherapy Conference.

"TRANSLATING SCIENCE INTO SURVIVAL"

September 16-19, 2015
Sheraton New York Times Square Hotel
New York City

The conference abstracts are available as an online supplement to Cancer Immunology Research at http://cancerimmunolres.aacrjournals.org/content/4/1_Supplement

 

 


CIMT Endeavour 2015

3rd CIMT Endeavour Workshop - Translating cancer science into products and companies

May 12, 2015 from 7:30-12:00 at Rheingoldhalle Congress Center in Mainz, Germany

Endeavour is a CIMT activity focusing on the translation and commercialization of cancer immunotherapies and diagnostics.

The 2015 workshop allowed scientists from the cancer immunotherapy community to present their innovation to business experts and venture capital representatives with a focus on funding initiatives, viable business models and product development. Participants shared and discussed the challenges that European and American biotech companies face in early, middle and late stage development.

CIMT Endeavour 2015 was organized in cooperation with Ci3, High Tech Coporate Services and Oslo Cancer Cluster.


CIMT Annual Meeting 2015

 
 

 
 

CIMT Annual Meeting 2014


Endeavour Workshop Impressions 2014


Poster Award Winners 2014


CIMT Annual Meeting 2013


Poster Award Winners 2013


Endeavour Workshop Impressions 2013


CIMT Annual Meeting 2012

 
 

Poster Award Winners 2012


CIMT Annual Meeting 2010


CIMT Annual Meeting 2009